Viral vectors are engineered viruses that are used to deliver genetic material into cells for various applications, such as gene therapy, vaccine development, and biotechnology research. These viruses ...
Industrial biotechnology has the potential to save the planet up to 2.5 billion tons of CO2 emissions per year and support building a sustainable future, a WWF report found. Industrial biotechnology ...
Artificial intelligence (AI) and laboratory automation have already shown promise for revolutionizing research in biotechnology. These technologies offer tremendous opportunities to be leveraged for ...
The combined effect of rapidly increasing domestication and production with increasing demand for seaweed products is likely to promote innovation in seaweed biotechnology. We, therefore, expect ...
It has been said that the genetic manipulation of plants is the reason why the Genomics Revolution—touted as the third technological revolution following the Industrial Revolution and the Computer ...
Discoveries in biotechnology have significantly improved our world in many ways—with the development of novel vaccines to curb pandemics, immunotherapies for cancer, environmental solutions, and other ...
On September 22, 2022, the U.S. Patent and Trademark Office (USPTO) conducted a live meeting for its Artificial Intelligence (AI) and Emerging Technologies (ET) Partnership Series. During this meeting ...
North America currently leads the DNA Synthesis Market due to its mature biotech ecosystem, heavy investment in genomics, and ...
"Biotechnology" is a term commonly applied to the development of new medicines and therapies, the development of genetically modified plants, biofuels, biological treatment, or the production of ...
Farming has become a challenge to smallholder farmers in many parts of the country. This is due to unpredictable weather and inaccessible climate-smart farm input. In recent months, climate ...
French engineer-virologist Thomas Mollet examines cells infected with a Sars-CoV-2 virus at the Biosafety level 3 laboratory in Saint-Herblain, France. Jean-Francois Monier/AFP via Getty Images ...
In trading on Monday, biotechnology shares were relative laggards, down on the day by about 2.3%. Helping drag down the group were shares of NPS Pharmaceuticals (NPSP), off about 15.8% and shares of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback